Audentes Therapeutics to Present at the ARM 5th Annual Cell & Gene Therapy Investor DayYahoo FinanceSAN FRANCISCO, April 17, 2017 /PRNewswire/ — Audentes Therapeutics, Inc. (BOLD), a biotechnology company focused on developing and commercializing … Continue reading
|
CRISPR Therapeutics’ (CRSP) Casebia Therapeutics JV Enters Collaboration Agreement with StrideBio
StreetInsider.com CRISPR Therapeutics (NASDAQ: CRSP) and Casebia Therapeutics, a joint-venture established by CRISPR Therapeutics and Bayer AG for developing CRISPR-based therapeutics in select disease areas, today announced they have signed a collaboration … |
Endpoints News |
CRISPR Therapeutics and Casebia Therapeutics Announce Exclusive Development and Option Agreement with …
GlobeNewswire (press release) BASEL, Switzerland and CAMBRIDGE, Mass. and DURHAM, N.C., April 17, 2017 (GLOBE NEWSWIRE) — CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases … CRISPR Therapeutics, Casebia ink AAV deal with StrideBio; Puma gets an AdComm date; Merrimack names new R&D …Endpoints News Chardan Capital Initiates Coverage on Crispr Therapeutics AG …Sports Perspectives Crispr Therapeutics AG (CRSP) Given Consensus Recommendation of “Strong Buy” by AnalystsThe Cerbat Gem Benchmark Monitor –BBNS –Chaffey Breeze all 13 news articles » |
The Scientist |
RNAi’s Future in Drug-Target Screening
The Scientist RNAi’s Future in Drug-Target Screening. A recent CRISPR study contradicted years of RNA interference research on a well-studied cancer drug target. But is it the last nail in the coffin for RNAi as a screening tool? By Catherine Offord | April 17, 2017. |
Billings Gazette |
Billings Clinic accredited for using stem cell method to ‘successfully treat’ a rare cancer
Billings Gazette So doctors a few decades ago created a workaround using stem cells, extracting them from the patient’s blood before administering the high-dose chemotherapy and then transplanting them back in to repair the damaged bone marrow after the chemo has … |
Digital Trends |
From corn to cattle, gene editing is about to supercharge agriculture
Digital Trends New gene editing tools like CRISPR/Cas9 now let scientists hack into genomes, make precise incisions, and insert desired traits into plants and animals. We’ll soon have corn with higher crop yields, mushrooms that don’t brown, pigs with more meat on … |